Doxylamine Succinate And Pyridoxine Hydrochloride Tablet, Delayed Release
Product Images NDC 0591-2132

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Doxylamine Succinate And Pyridoxine Hydrochloride (NDC 0591-2132). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Actavis Pharma, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural Formula (Doxylamine Succinate And Pyridoxine Hydrochloride 1)

Chemical structure diagram showing the molecular formula of doxylamine succinate, including the succinate molecule. The structure depicts aromatic rings and functional groups characteristic of the active ingredient in the drug Doxylamine succinate and pyridoxine hydrochloride.*

FDA Label Image

Structural Formula (Doxylamine Succinate And Pyridoxine Hydrochloride 2)

Chemical structure of pyridoxine hydrochloride, one of the active ingredients in Doxylamine succinate and pyridoxine hydrochloride tablets, delayed-release oral dosage form.*

FDA Label Image

Updated Lbl (Doxylamine Succinate And Pyridoxine Hydrochloride 3)

Label for Doxylamine Succinate and Pyridoxine Hydrochloride Delayed-Release Tablets 10 mg/10 mg by Actavis Pharma, Inc. The label includes a warning to swallow tablets whole and not to crush, chew, or split them. It also states the package contains 100 tablets. The label provides dosage, storage, and manufacturer information, along with a barcode and NDC 0591-2132-01.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.